Report: McKesson looking to divest tech solutions business

According to a new report, McKesson may divest its technology solutions unit, which provides health IT solutions to more than half of all health systems in the United States and 76 percent of all health systems with more than 200 beds.

Sources close to the situation have told The Wall Street Journal that McKesson is considering options such as a sale or a merger. No official deal is in place at this time.

The Wall Street Journal also speculated that the technology solutions unit could be worth more than $5 billion if a deal is finalized.

McKesson officials told RadiologyBusiness.com they will not comment on “rumors and speculation.”

More information about McKesson’s technology solutions business can be read on the company’s website.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup